Excitotoxicity in Neurological Diseases: New Therapeutic Challenge - Image 1

Price loading...

Springer Excitotoxicity in Neurological Diseases: New Therapeutic Challenge

Name: Excitotoxicity in Neurological Diseases: New Therapeutic Challenge
Brand: Springer

Neurology & Clinical Neurophysiology

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

It can be reasonably anticipated that, over the next generations, the proportion of elderly people will remarkably increase and, with this, the number ofpersons suffering from acute (e.g. cerebral ischemia) or chronic neurodegenerative disorders. To date, approved drugs only alleviate the symptoms ofthese diseases (for instance, acetylcholinesterase inhibitors in Alzheimer disease and L-dopa and dopamine-agonists in Parkinson disease), while none seems to stop the progression of the degenerative processes underlying them. The development of effective preventive or protective therapies has been impeded by the limitations of our knowledge of the causes and the mechanisms by which neurons die in neurodegenerative disorders. Evidence accumulated in the past 20 years indicated that the major excitatory neurotransmitter glutamate may play a role as neurotoxin in several conditions. In particular, the glutamatergic system dysfunction seems to be an early event working as a common pathway in the pathogenesis ofa large number ofacute and chronic neurological disorders, in strict conjunction with other important mechanisms, such as oxidative stress and energetic failure, and probably triggered by different mechanisms in various diseases. In consideration of that, drug discovery efforts over the last decade have been focused on the search for drugs that either reduce glutamate synaptic levels or block its postsynaptic effects. Despite numerous reviews on basic mechanisms and clinical aspects ofthe excitotoxic phenomenon, so far no comprehensive book has covered the topic in all its complexity, starting from basic pharmacological mechanisms, to .animal models of diseases and finally to clinical pathogenic and therapeutic implications.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 146134736X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain: Amazon UK
Publication Date: 17 October 2012
Listed Since: 03 March 2013

Barcode

No barcode data available

Springer Excitotoxicity in Neurological Diseases: New Therapeutic Challenge

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

EXCITOTOXICITY FUNDAMENTAL: Fundamental Concepts, Pathophysiology & Treatment Strategies (Neuroscience Research Progress)

Excitatory Amino Acids: Clinical Results with Antagonists

Excitatory Amino Acids and Second Messenger Systems: 3 (Ernst Schering Foundation Symposium Proceedings)

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases

Neurochemical Aspects of Excitotoxicity

Acute Neuronal Injury: The Role of Excitotoxic Programmed Cell Death Mechanisms

Humana - The Metabotropic Glutamate Receptors Book

Natural Products and Neuroprotection

Enzymes in Neurodegenerative Disorders: Mechanism and Therapeutic Potentials

Intracellular Traffic and Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease)

METABOTROPIC GLUTAMATE RECEPTORS MOLE: Molecular Mechanisms, Role in Neurological Disorders & Pharmacological Effects (Neuroscience Research Progress)

Handbook of Neurotoxicity

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Neurodegenerative Disorders as Systemic Diseases

Oxidative Stress and Neurodegenerative Disorders

Neurochemistry: Molecular and Cellular Clinical Applications

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Psychiatry - Theory, Applications and Treatments)

Advances in Neuropharmacology: Drugs and Therapeutics

The Glutamate/GABA-Glutamine Cycle: Amino Acid Neurotransmitter Homeostasis: 13 (Advances in Neurobiology, 13)

Cellular Regulation of Glutamate Receptors in Central Neurons: Intracellular Signaling, Receptor Trafficking, Protease Proteolysis

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

A Review on Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics

Principles of Neurochemistry: Fundamentals and Applications